These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20821933)

  • 21. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
    Dallongevillle J; De Bacquer D; Heidrich J; De Backer G; Prugger C; Kotseva K; Montaye M; Amouyel P;
    Heart; 2010 Nov; 96(21):1744-9. PubMed ID: 20956490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a gender gap in secondary prevention of coronary artery disease in Turkey?
    Koçyiğit D; Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
    Turk Kardiyol Dern Ars; 2018 Dec; 46(8):683-691. PubMed ID: 30516526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.
    Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H
    Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys.
    De Smedt D; De Sutter J; De Pauw M; Vandekerckhove H; Trouerbach J; De Backer G; Willems AM; Pardaens S; Vervaet P; Deweerdt N; De Bacquer D
    Acta Cardiol; 2019 Feb; 74(1):21-27. PubMed ID: 29458303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys.
    Mayer O; Simon J; Rosolová H; De Bacquer D;
    Cent Eur J Public Health; 2002 Sep; 10(3):107-11. PubMed ID: 12298341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifestyle and physiological risk factor profiles six weeks after an acute cardiac event: are patients achieving recommended targets for secondary prevention?
    Murphy BM; Worcester MU; Goble AJ; Mitchell F; Navaratnam H; Higgins RO; Elliott PC; Le Grande MR
    Heart Lung Circ; 2011 Jul; 20(7):446-51. PubMed ID: 21440501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.
    Wagner M; Gelbrich G; Kircher J; Kotseva K; Wood D; Morbach C; Leyh R; Ertl G; Karmann W; Störk S; Heuschmann PU
    Int J Behav Med; 2018 Jun; 25(3):283-293. PubMed ID: 29086252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
    Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
    Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys.
    Ungethüm K; Wiedmann S; Wagner M; Leyh R; Ertl G; Frantz S; Geisler T; Karmann W; Prondzinsky R; Herdeg C; Noutsias M; Ludwig T; Käs J; Klocke B; Krapp J; Wood D; Kotseva K; Störk S; Heuschmann PU
    Clin Res Cardiol; 2023 Feb; 112(2):285-298. PubMed ID: 36166067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between the Finnish Diabetes risk Score and the severity of coronary artery disease.
    Djurić P; Mladenović Z; Grdinić A; Tavčiovski D; Spasić M; Davičević-Elez Z
    Vojnosanit Pregl; 2014 May; 71(5):474-80. PubMed ID: 26137713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure is insufficiently controlled in European patients with established coronary heart disease.
    Boersma E; Keil U; De Bacquer D; De Backer G; Pyörälä K; Poldermans D; Leprotti C; Pilotto L; de Swart E; Deckers JW; Heidrich J; Sans S; Kotseva K; Wood D; Ambrosio GB;
    J Hypertens; 2003 Oct; 21(10):1831-40. PubMed ID: 14508188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversing social disadvantage in secondary prevention of coronary heart disease.
    Jelinek MV; Santamaria JD; Best JD; Thompson DR; Tonkin AM; Vale MJ
    Int J Cardiol; 2014 Feb; 171(3):346-50. PubMed ID: 24411209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential for cholesterol lowering in secondary prevention of coronary heart disease in europe: findings from EUROASPIRE study. European Action on Secondary Prevention through Intervention to Reduce Events.
    Vanuzzo D; Pilotto L; Ambrosio GB; Pyörälä K; Lehto S; De Bacquer D; De Backer G; Wood D;
    Atherosclerosis; 2000 Dec; 153(2):505-17. PubMed ID: 11164441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.